Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Cash & Equivalents (2016 - 2025)

Marchex (MCHX) has disclosed Cash & Equivalents for 16 consecutive years, with $10.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 14.55% to $10.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.3 million, a 14.55% decrease, with the full-year FY2024 number at $12.8 million, down 12.6% from a year prior.
  • Cash & Equivalents was $10.3 million for Q3 2025 at Marchex, down from $10.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $28.2 million in Q1 2021 to a low of $10.0 million in Q1 2025.
  • A 5-year average of $18.0 million and a median of $14.6 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: fell 10.77% in 2022, then crashed 43.1% in 2023.
  • Marchex's Cash & Equivalents stood at $27.1 million in 2021, then fell by 24.41% to $20.5 million in 2022, then fell by 28.66% to $14.6 million in 2023, then dropped by 12.6% to $12.8 million in 2024, then decreased by 19.16% to $10.3 million in 2025.
  • Per Business Quant, the three most recent readings for MCHX's Cash & Equivalents are $10.3 million (Q3 2025), $10.5 million (Q2 2025), and $10.0 million (Q1 2025).